Controversies in Allergy
e
Electronic Cigarettes: A Pro Con Review of the
Current Literature
CoralX.Giovacchini,MDa,LauraE.CrottyAlexander,MDb,c,andLorettaG.Que,MDa Durham,NC;andSanDiego,Calif
Electroniccigarettes (e-cigarettes, e-cigs,orelectronic nicotine users. (cid:1)2022TheAuthors. PublishedbyElsevierInc. on
delivery systems)arebattery-operated devicestypically behalf oftheAmerican AcademyofAllergy,Asthma&
containingglyceroland/orpropyleneglycol-basedsolutionswith Immunology. ThisisanopenaccessarticleundertheCCBY-
varyingnicotinecontent,known ase-liquids.Although NC-NDlicense (http://creativecommons.org/licenses/by-nc-nd/
e-cigarettes wereoriginallydeveloped asapotentially less 4.0/).(JAllergy ClinImmunol Pract2022;10:2843-51)
harmfulalternativetotraditional combustibletobaccocigarette
Key words: E-cigarette; Nicotine; Smoking cessation; EVALI;
smokers,severalfactorshavedriventheirpopularityamong
Dualuse
smokersandnonsmokersalike, includingtheirsleekproduct
designs,innumerable appealingflavors,lack ofcombustible
smokeand odor,andhighpotential nicotineconcentrations. INTRODUCTION
Furthermore, manyadvocateshavepromoted theideathat Electronic cigarettes (also known as e-cigarettes, e-cigs, or
e-cigarettes aresafetouse, orat leastsaferthanconventional electronic nicotine delivery systems [ENDS]) are battery-
tobacco,despitelimitedlongitudinaldatatosupport these operated nicotine delivery devices typically filled with glycerol
claims.Here,weexaminewhatisknownabouttheimpactsof and propylene glycol-based solutions with varying nicotine
e-cigarette useontraditionalcigarette smokingcessation,lung content, known as e-liquids.1,2 Although e-cigarettes were his-
health,andyouthandyoung adulttobaccoproductexposure. torically developed to supplant traditional combustible tobacco
Uponreviewofthecurrently available literature, thenegative use with a less harmful alternative, several factors have driven
effectsofe-cigaretteuseseemtooutweighanypotentialbenefit, e-cigarettepopularity,includingtheirmanyappealingflavors,the
becausetheavailableevidencedoesnotconfirmtheuseof lack of combustible smoke and odor, sleek profiles, and high
e-cigarettes asaneffectivestrategyfor supportingtraditional potentialnicotineconcentrations.Furthermore,manyconsumers
combustibletobaccocigarette smokingcessation,particularly andadvocateshavepromotedtheideathate-cigarettesaresafeto
giventheemerging adverseeffectsonlunghealthandthe use,oratleastsaferthanconventionaltobacco.However,limited
potential futurepublichealth effectsofe-cigarette adoption longitudinal data exist to support those suppositions, given the
amongaburgeoningnewgenerationoftobaccoproduct relativelyrecentemergenceofe-cigarettesasaprominenttobacco
product.Here,weexaminewhatisknownabouttheimpactsof
e-cigarette use on traditional cigarette smoking cessation, lung
aDivisionofPulmonary,Allergy,andCriticalCare,DukeUniversityHealthSystem,
health, and youth and young adult tobacco product exposure.
Durham,NC
bPulmonaryCriticalCareSection,VASanDiegoHealthcareSystem,SanDiego,
Calif ELECTRONIC CIGARETTE USE AND SMOKING
cDivisionofPulmonary,CriticalCare,Sleep,andPhysiology,UniversityofCali- CESSATION
forniaSanDiego,SanDiego,Calif
Development and current use
DrCrottyAlexander’ssalarywassupportedinpartbyVeteransAffairsMeritAward
1I01BX004767(CrottyAlexander),NationalInstitutesofHealth(NIH)National The earliest patent for an e-cigarette was granted in August
Heart,Lung,andBloodInstituteAwardK24HL155884(CrottyAlexander),and 1965 to Herbert A. Gilbert (US Patent No. 3,200,819),3 who
Tobacco-RelatedDiseaseResearchProgramAwardsT32SR5359(Emory/Crotty designeda“smokelessnontobaccocigarette”withmultipleflavor
Alexander)andT30IP0965(CrottyAlexander).DrQue’ssalaryissupportedin
options yet without nicotine, with the intent of replacing the
partbyNIHNationalHeart,Lung,andBloodInstituteAwardsR01HL146542
(Holguin/Que), R01HL153641 (Que), R01HL136917 (Dixon), NIH National combustible tobacco cigarette with a safer, less harmful alterna-
Institute of Environmental Health Sciences Award R01ES027574 (Tighe), and tive.4 However, in focus groups run by tobacco companies,
NIHNationalInstituteofAllergyandInfectiousDiseasesAwardHHSN272000- smokers did not find the aerosol produced by Gilbert’s device
TO22-TaskD(Walters/Que)andtheAmericanLungAssociation-AirwaysClin-
appealing, likely because of the absence of nicotine and the
icalResearchCenter.
Conflicts of interest: The authors declare that they have no relevant conflicts of subsequent inability to activate the dopamine reward system.
interest. The device never made it to market.
ReceivedforpublicationApril28,2022;revisedJune27,2022;acceptedforpub- In the mid-2000s, the modern e-cigarette was invented and
licationJuly8,2022. use skyrocketed in popularity in the United States and Europe,
AvailableonlineJuly21,2022.
especiallyamongyouthsandyoungadults.Somefactorsdriving
Correspondingauthor:LauraE.CrottyAlexander,MD,9500GilmanDr,MC9111J,
San Diego, Calif 92093. E-mail: lca@ucsd.edu. Or: Loretta G. Que, Rm 279 the popularity of these products include the availability of
MSRB1,203ResearchDr,Durham,NC27710E-mail:loretta.que@duke.edu thousands of flavors allowing for a personalized product selec-
2213-2198 tion,5,6 minimal regulation by the government resulting in the
(cid:1)2022TheAuthors.PublishedbyElsevierInc.onbehalfoftheAmericanAcademy
perceptionoftheirbeinglessharmfulthancombustibletobacco
ofAllergy,Asthma&Immunology.ThisisanopenaccessarticleundertheCC
products,7,8 and extensive marketing by manufacturers as
BY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).
https://doi.org/10.1016/j.jaip.2022.07.009 smoking cessation aids.9 However, to date, no clear consensus
28432844 GIOVACCHINIETAL JALLERGYCLINIMMUNOLPRACT
NOVEMBER2022
has emerged regarding the utility of e-cigarettes for smoking volatile organic compounds. Switching from exclusive cigarette
cessation, and e-cigarettes have not been approved by the Food use to exclusive e-cigarette use (1.2%) resulted in a decreased
and Drug Administration (FDA) Center for Drug Evaluation urinarytoxicantcontent;however,mostparticipantsmaintained
and Research for this purpose. Although several randomized exclusive e-cigarette use or became dual users of combustible
controlled trials and observational studies have been conducted cigarettes and e-cigarettes. In these individuals, levels of urinary
during the past decade to address this specific question, many toxicants did not decrease.18 Most dual users maintained dual-
earlier studies did not include control groups, used early- use status (37.9%) or transitioned back to exclusive combus-
generation e-cigarette types with poor nicotine delivery, or tible cigarette use (49.1%) 1 year later. The authors concluded
wereinconclusiveowingtothesmallsamplesizeorchallengesin that e-cigarettes tended to be used as supplements to conven-
the study design. tional cigarettes, resulting in dual use and reduced efficacy as
smoking cessation aids.
E-cigarettes as smoking cessation aids
Short-termstudies(lessthan1year)published toaddressthe
efficacy of e-cigarettes as smoking cessation aids have yielded E-cigarettes and nicotine replacement therapy
dichotomous results.10-13 A 2021 Cochrane analysis evaluated Treatment with nicotine replacement therapy (NRT) and
the effect of e-cigarette consumer product use on smoking combination therapies for smoking cessation achieves absti-
cessationandfoundthatinalladultsmokers(oddsratio[OR]¼ nence rates of approximately 26% at 6 months and 20% at 1
0.947; 95% CI, 0.772-1.1600) and smokers motivated to quit year.19-21 Compared with traditional NRT, epidemiologic
smoking (OR ¼ 0.851; 95% CI, 0.684-1.057), e-cigarette studies show that e-cigarettes can be more effective than NRT
consumer product use was not significantly associated with a alone in achieving smoking cessation. Walker and colleagues22
higherquitrate.14Incontrast,quitrateswerehigherincigarette examined the effects of dual NRT using nicotine patches and
smokers who used e-cigarettes daily (OR¼ 1.529; 95% CI, nicotine-containinge-cigarettescomparedwithnicotinepatches
1.158-2.019) relative to smokers who use e-cigarettes less than alone and nicotine-free e-cigarettes. Unfortunately, a control
daily (OR¼ 0.514; 95% CI,0.402-0.665).11,14 When pre- cohort using e-cigarettes alone was not included in the study
scribedassmokingcessationaidsandadministeredfreeofcostin design.Exhaledcarbonmonoxidewasusedtoverifycontinuous
randomized control trials, e-cigarettes offer little benefit over combustibletobaccoabstinenceat6months.Participantsinthe
usual care or no treatment.10,12 nicotine patches andnicotine e-cigarette group hada modestly
Furthermore,inthelongestobservationalstudyperformedto higher quit rate (7%) than those in the nicotine patches and
date, Flacco et al11 found no evidence that e-cigarette use nicotine-free e-cigarette group (4%) (risk difference ¼ 2.99;
95%CI,0.17-5.81).22Thegrouptreatedwithnicotinepatches
increased smoking cessation rates over a 6-year period (2013-
2019),norwasthereevidenceofharmreductionine-cigaretteor and nicotine e-cigarettes received higher total nicotine
dual users (those using both e-cigarettes and combustible ciga- replacement levels compared with the patches-alone group,
rettes) compared with cigarette smokers. Abstinence from whichmayexplaintheslightlyhigherabstinencerate,suchthat
theroleofthespecificnicotinedeliverysystemwasnotdirectly
combustible tobacco use was assessed with exhaled carbon
monoxide testing in 228 e-cigarette users (all ex-smokers), 469 assessed in this study. The quit rate in the nicotine patches-
cigarette smokers, and 215 dual users. Among e-cigarette users, alone groups was 2% (risk difference ¼ 4.60; 95% CI, 1.11-
64.0%remainedtobaccoabstinent.Tobaccocessationrateswere 8.09), which is extremely low compared with similar NRT
equivalent in both dual users and tobacco smokers (38.6% vs studies.Thisraisesconcernsregardingthestudydesignandthe
33.9%), respectively. The authors found that although the presence of extra-treatment factors that adversely influenced
NRT.21
switch from combustible cigarettes to e-cigarettes supported
Thefindingthate-cigarettesaresuperiortoNRTinachieving
abstinence from conventional cigarette use, the continued used
ofe-cigarettesinadditiontosmokingcigarettesdidnotimprove smokingcessationwasalsonotedina2019studyinwhich886
smoking cessation or reduction.11 adult smokers were randomly assigned to receive either NRT
(n¼447)oranicotine-containinge-cigarettestarterpack(n¼
E-cigarettes and the harm reduction principle 439).Inthisstudy,participantsalsoreceivedweeklyface-to-face
Harmreductionviae-cigaretteusehasalsobeenevaluatedby counseling for 1 year. The primary outcome was sustained
measuring tobacco-specific toxicants and carcinogens. Like cig- smokingabstinenceat52weeks.Theauthorsfoundthat18%of
arettes, aerosols from e-cigarettes have been found to contain participants who used e-cigarettes for smoking cessation aids
nicotine, nitrosamines, carbonyl compounds, heavy metals, and were no longer smoking conventional tobacco a year later
particulate matter.12,13,15Although presentinsmaller quantities compared with 9.9% of participants who used NRT to quit
compared with combustible tobacco products, these chemicals smoking(relativerisk¼1.83;95%CI,1.30-2.58;P<.001).23
arewell-knownfortheiraddictivenatureandtoxicity.16,17Inthe However,amonge-cigaretteusers,80%(63/79)werestillvaping
national cohort Population Assessment of Tobacco and Health a year later (and thus using a tobacco product), compared with
(PATH) study including 3,211 participants consisting of exclu- only9%ofparticipantsintheNRTgroupstillusingNRT(four
sive cigarette smokers (79.7%), exclusive e-cigarette users of 44),and110participantsinthee-cigarette group(25%)had
(5.3%),anddualusers(15.0%)fromwaves1and2,fiveurinary become dual users.23 Although these findings suggest that
biomarkers were examined using multivariable regression e-cigarettes may be helpful for traditional tobacco cigarette
models:(1)nicotinemetabolitesandminortobaccoalkaloids,(2) cessation in smokers, they also highlight the potential for new
tobacco-specific nitrosamines, (3) metals (heavy metals and sustained dependency anduse of e-cigarettes whenused forthis
speciatedarsenic),(4)polycyclicaromatichydrocarbons,and(5) purpose among former smokers.JALLERGYCLINIMMUNOLPRACT GIOVACCHINIETAL 2845
VOLUME10,NUMBER11
E-cigarettes and addictive potential TABLEI. Reportedeffectsofelectroniccigarettesonlunghealth
The addictive potential of e-cigarettes was evaluated in Humanreports Animalstudies
another 2019 study using the Fagerstrom test for nicotine
Acutelunginjury/electroniccigarette Airwayhyperreactivity/
dependence, a 25-item questionnaire modified to analyze nico- orvapingproductuse-associated bronchospasm
tine dependence and patterns and attitudes toward using e-cig- lunginjury
arettes and combustible cigarettes.24 Thirty e-cigarette users, 30 Acuterespiratorydistresssyndrome Alteredimmunecellfunction
smokers,and30dualuserswereevaluated.Habitsandbehaviors Alteredimmunecellfunction Alteredgeneexpression
associated with using e-cigarettes did not differ significantly be-
Alteredepithelialcellfunction Cellularcytotoxicity
tween exclusive e-cigarette users and dual users. Surprisingly,
Alteredepithelialcellproteinand DNAstrandbreaks
nicotine dependence as measured using the Fagerstrom test for geneexpression
nicotinedependencewastwiceashighine-cigaretteusers(mean,
Alveolarhemorrhage Emphysema
3.5)comparedwithtraditionalcigarettesmokers(mean,1.6;P<
Asthmaandchronicobstructive IncreasedMUC5ACmucin/
.001),25 affirming that e-cigarettes can be powerful activators of pulmonarydiseaseexacerbations/ gobletcellmetaplasia
nicotine addiction pathways in the brain, and that using these increasedsymptomatology
devicescanconveyanaddictivepotentialsimilartoconventional Bronchiolitis Increasedsusceptibilityto
tobacco products. infection
Equally disturbing are further data from the PATH cohort Bronchitis/productivebronchitis Increasedsusceptibilityto
study examining the addictive potential of e-cigarettes in 2,273 acuterespiratorydistress
adult former tobacco smokers from waves 1 to 4 (2013-2018). syndrome
Adult former smokers who reported using e-cigarettes after Cough Inhibitionofciliarybeating
wave 1 and who had not used traditional cigarettes during Eosinophilicpneumonia Nasalsquamousmetaplasia
wave 1 of the PATH trial were found to be at increased risk Hypersensitivitypneumonitis Oxidativestress
for traditional cigarette smoking relapse (adjusted hazard IncreasedMUC5ACmucin Pulmonaryfibrosis
ratio ¼ 1.63; 95% CI, 1.04-2.53 in recent former smokers; Lipoidpneumonia Tumorigenesis
unweighted n ¼ 304, and adjusted hazard ratio ¼ 3.79; 95% Organizingpneumonia
CI, 1.75-8.20; unweighted n ¼ 1,554 in long-term former Shortnessofbreath
smokers).26
Wheezing
Aseparateanalysis of26,446adultscompletingtwowavesof
PATH(2013-2014and2014-2015)alsoshowedthate-cigarette
use increased rates of new combustible tobacco product use in
adults,comparedwithadultswhohadneverusede-cigarettes(P ELECTRONICCIGARETTEUSEANDLUNGDISEASE
< .001).Adults whohad never used e-cigarettes atbaseline but Whereas wehavehadover140years towitness lung diseases
reportedevertryinge-cigaretteswerefourtimesaslikelytohave causedbyconventionaltobacco,wehavehadlessthan20yearsto
transitioned to ever smoking combustible cigarettes than never identifyandclassifylungdiseasesassociatedwithe-cigaretteuse.In
smokerswhohadnotusede-cigarettes(OR¼4.0;95%CI,2.6- addition, we have only recently begun regularly asking patients
6.1). Adults who used e-cigarettes in the past 30 days were six aboutanddocumentinge-cigaretteuseinmedicalrecords.Assuch,
times as likely to have transitioned from never to ever combus- data are limited and often rely on animal studies, case reports,
tiblecigarettesmokers(OR¼6.6;95%CI,3.7-11.8)andeight series, and cohorts describing associated lung effects and symp-
times more likely to have become established combustible ciga- tomatology.TableIlistssomeofthereportedlunghealtheffectsof
rette smokers (OR ¼ 8.0; 95% CI, 2.8-22.7) than those who e-cigaretteuseinbothhumanandanimalstudies.
had never used e-cigarettes. These studies emphasize the
importance of discouraging e-cigarette use in former smokers Cytotoxic effects
who had successfully quit smoking, and of advising never- Whereas e-cigarettes have not been around long enough to
smokers against initiating use.27 determine whether consistent use leads to common tobacco
Finally, Beard and colleagues28 examined how far changes in producterelated lung diseases such as emphysema, chronic
the prevalence of e-cigarette and licensed NRT use while bronchitis, interstitial lung diseases, or lung cancer, in vitro and
smokingwereaccompaniedbychangesincigaretteconsumption invivostudiesusinganimalmodelshaveconsistentlyfoundtoxic
at the population level in active cigarette smokers. This obser- andprocarcinogeniceffectsofe-cigaretteaerosols.Oneofthefirst
vational study performed in England between 2006 and 2016 studies,byYuetal,29foundthatexposuretoe-cigaretteaerosolsled
showed no statistically significant associations between changes toDNAstrandbreaksandcytotoxicityacrosscelllines.Notably,
in e-cigarette use (b ¼ e0.012; 95% CI, e0.026 to 0.002) or thiscellularandmoleculardamageknowntodrivetumorigenesis
NRT use (b ¼ 0.015; 95% CI, e0.026 to 0.055) and daily was independent of nicotine. Since that publication in 2016,
cigarette consumption.28 severalgroupshaveidentifiedfurtherDNAdamagingandDNA-
Taken together, although some studies have shown that repair limiting effects of e-cigarettes,30-32 as well as direct cyto-
e-cigarette use may lead to short-term smoking cessation, they toxic30,33-36andcarcinogenic31,37effectsofe-cigarettes.
represent an inferior treatment approach relative to well-proven
smoking cessation strategies, and their addictive potential com- Cellular immunomodulation
bined with the lack of proven harm reduction supports caution Immunecells,whichareimportantpathologicallyacrosslung
against their use for smoking cessation. diseasessuchaspneumonia,interstitiallungdisease,asthma,and2846 GIOVACCHINIETAL JALLERGYCLINIMMUNOLPRACT
NOVEMBER2022
cancer, have been found to be phenotypically and functionally phenotypic changes across macrophages, neutrophils, and
altered and immunomodulated by e-cigarette aerosols and their epithelial cells suggests that e-cigarette use affects the innate
components. This is particularly concerning in the setting of immune system, reducing functional abilities to response to in-
infection, because the diminishedability of hostdefense cells to fectious challenges.
clear pathogens (bacteria, viral, and fungal) predicts that e-ciga-
retteusersmayhavehigherratesandhigherseverityofinfectious Potential for clinical disease development
diseases.Throughmurinestudies,datainthisareahaveemerged Murine models are one of our only tools with which to
in both airway andlung parenchymal immune cells,38,39raising determine whether e-cigarette use may cause disease over time,
concernregardingincreasedsusceptibilitytopneumonia,aswell becauseexposureofmicetoe-cigaretteaerosolsformonthsisthe
as in circulating immune cells and those within distant organs equivalent of years to decades in humans.57 Broadly, murine
(heart and colon), potentially increasing susceptibility to models have demonstrated that emphysema can occur owing to
bacteremia,sepsis,andmultiple-organfailureinthesettingofan e-cigarettes, but it may be a factor of both genetics and expo-
sure,58-60andthatpulmonaryfibrosismaybepromotedbyusing
infectious challenge. Nevertheless, further studies are needed to
ensurethesefindingsaresimilarlyborneoutinhumancellswith e-cigarettes.60 In addition, multiple groups have shown dimin-
typical e-cigarette product use. ished host responses to infectious challenges in the setting of
Accordingly,someofthemostcommonquestionsduringthe e-cigarette aerosol inhalation (bacterial and viral),51,55 and
COVID-19epidemicwerewhethere-cigaretteuseincreasedthe increased pathogen virulence (bacterial and fungal).35,61 One of
risk for being infected with SARS-CoV-2 and whether vaping themostshockingstudiesof2019wasthearticlebyTangetal,37
increased severity and mortality. Although these questions have which demonstrated an increase in lung adenocarcinoma
notyetbeenansweredtooursatisfactioninhumansubjects,the tumorigenesis in the setting of a year of daily e-cigarette aerosol
data are most supportive of e-cigarette users having more respi- exposure, depending on the presence of nicotine within the
ratory symptoms even before viral infections,40-43 with poten- aerosols. Finally, e-cigarette exposure daily for months has been
tially increased symptoms in the setting of COVID-19.44 One showntocausediseasebeyondthelung,includingcardiac,renal,
national cross-sectional survey of adolescents and young adults and hepatic fibrosis, neuroinflammation in the central nervous
(aged 13-24 years) performed in May 2020 found that both system, and altered inflammatory states in the heart and
e-cigarette users and dual e-cigarette and cigarette users were colon.56,62
morelikelytoreceiveadiagnosisofCOVID-19comparedwith Although much is still unknown, there are multiple reports
nonusers, and ever-users of e-cigarettes were five times more identifyinge-cigaretteuseasthecauseofavarietyofmoreacute
likely to test positive (OR ¼ 5.05; 95% CI, 1.82-13.96),45 andsubacutelungdiseases,includingeosinophilicpneumonia,63
although the authors noted that there were likely both immu- hypersensitivity pneumonitis,64,65 bronchiolitis,66 organizing
nologic and social contributors to positive testing among pneumonia,67 alveolar hemorrhage,68,69 and acute respiratory
e-cigarette-usingyoungadults.Therearenoconvincingdatathat distress syndrome. In many of these cases, patients became
e-cigaretteuseleadstogreaterdiseaseseverityorhighermortality critically ill before clinicians could recognize or identify the
in COVID-19.46,47 However, murine and in vitro data suggest inhalantuseasapotentialdriver.Thus,thesefewcasesthatwere
that daily e-cigarette use leads to increased angiotensin convert- identified as related to e-cigarettes suggest that many more may
ing enzyme-2expression48-50 andis associated with more severe be occurring across the world but are not being identified as
acute lung injury in the setting of viral infections, including a related to vaping.
murine coronavirus and influenza virus.51,52 Thus, the current
conclusion is that e-cigarette use likely leads to altered inflam- The e-cigarette or vaping product use-associated
matory responses in the lungs, which potentially will influence lung injury epidemic
disease severity in some viral lung infections. In 2019, a lung disease specific to vaping of tetrahydrocan-
Data on immunophenotype changes induced in innate im- nabinol(THC)wasidentified:e-cigaretteorvapingproductuse-
mune cells, both present in the lungs at baseline and recruited associated lung injury.70,71 Many of the affected patients were
duringinflammatoryandinfectiouschallenges,canbeinsightful teenagersoryoungadults,andsomerequiredourhighestlevelof
as to why e-cigarette use may lead to altered inflammatory re- support, extracorporeal membrane oxygenation.65,66,72 Whereas
sponses in the lungs. Human alveolar macrophages and murine the e-cigarette or vaping product use-associated lung injury
bone marrowederived macrophages exposed to e-cigarette epidemicisadiseaseofTHCvapers(caseshavecontinuedtobe
aerosols have decreased phagocytosis and efferocytosis.33,53 Hu- identifiedinto2022),thisepidemicbroughttolightthedangers
manmacrophagesdifferentiatedfromthemonocyticTHP-1cell ofinhalingchemicalsthathaveneverbeenassessedforpotential
line exposed to multiple common components of e-liquids pulmonary(andwhole-body)toxicity.Ittookover60deathsand
(nicotine, propylene glycol, glycerol, and numerous flavorants) thousands of vapers falling ill before vitamin E acetate was
showdiminishedphagocytosisofbacteriaafternicotineorflavor identified as the causal agent, which was being added to THC
exposure, and diminished inflammatory cytokine secretion after containing e-liquids by retailers. Of note, vitamin E does not
exposure to any e-liquid component, including flavors.54 Neu- sounddangerous,andliquidformulationsarewidelyavailablein
trophils from the circulation of e-cigarette aerosols as well as stores and online. Many people ingest it or apply it topically,
those exposed to e-cigarette aerosol extracts were found to have becauseitisgenerallyconsideredsafeforconsumeruse.Thus,it
altered neutrophil extracellular trap formation and diminished cameasasurprisetomanytofindthatitwashighlytoxictolung
antimicrobialfunction.55Epithelialcells,whichthemselveshave cellswheninhaled.Becausetherehasbeennoregulationofwhat
multipleantimicrobialandinflammatoryfunctions,demonstrate chemicals can and cannot be added to nicotine or THC e-liq-
increasedpermeabilityanddiminishedsignalingforhelpaftere- uids, it may be only a matter of time until the next lung injury
cigarette exposure.56 This combination of functional and epidemic owing to vaping devices occurs.JALLERGYCLINIMMUNOLPRACT GIOVACCHINIETAL 2847
VOLUME10,NUMBER11
Secondhand vapor exposure product is conventional tobacco; less than 1% of young e-ciga-
One area in which the theoretical potential for rette users in that study became established traditional cigarette
e-cigaretteerelated harm reduction has been proposed is in smokers. Similarly, using data from the first three annual waves
secondhandsmoke (SHS)exposures. Itiswell-documented that ofthenationallyrepresentative sampleofbaseline tobacco-naive
secondhand smoke exposure leads to suppressed lung develop- youths enrolled in the PATH study, Xu et al79 found that the
mentinchildrenandincreaseddevelopmentofobstructivelung riskforpast30-daycombustiblecigaretteusewascomparatively
disease, and promotes the development of lung cancer in sevenfold lower when youths started with an e-cigarette
otherwise nonsmokers. Because e-cigarettes have been touted as compared with a combustible cigarette. One hypothesis as to
healthierandsaferthanconventionaltobacco,andbecauseofthe why using e-cigarettes first may lead to these youths and young
less averse smell and look of e-cigarette aerosols compared with adults sticking with e-cigarettes alone comes from Jankowski
conventional tobacco smoke, many parents who switched to et al,25 who found that nicotine dependence was two times
e-cigarettesbeganvapingintheirhomesandcarsinthepresence greater in young (mean age, 22.4 years) e-cigarette users versus
of their children. This has led to high secondhand e-cigarette conventional cigarette smokers(meanage,3.54vs1.64years; P
aerosol exposures in those who live with e-cigarette users. <.001).However,unlikeinthestudybyShahabetal,Xuetal
However, we now have data demonstrating that lung diseases importantlynotedthatamongtobacco-naiveyouthinthePATH
and respiratory symptoms are occurring as the result of second- study,theinitiationofe-cigaretteusewasassociatedwithgreater
hande-cigaretteaerosolexposure.73Galiatsatosetal74identified risk for subsequent initiation of combustible cigarette smoking
acaseofhypersensitivitypneumonitisresultingfromsecondhand (OR ¼ 3.42; 95% CI, 9.68-68.72) as well as past 30-day
e-cigarette aerosol exposure, whereas Alnajem et al73 showed an combustible cigarette use (OR ¼ 2.88; 95% CI, 1.22-6.86).
increase in wheeze and asthma. Accordingly, secondhand However, this risk was higher when youths started with a
e-cigarette exposure may not be as innocuous as previously combustible cigarette.79
considered, and further studies are needed to explore the po-
tential future implications of e-cigarette use on lung health. Transition to traditional cigarette use
Unfortunately, numerous other prospective, longitudinal
studies have demonstrated the strong association between the
ELECTRONIC CIAGARETTE USE AMONG onset of youths’ e-cigarette use and subsequent traditional ciga-
ADOLESCENTS AND YOUNG ADULTS rette smoking.80-84 For example, in their longitudinal survey of
Thepastdecadehasseenasharpriseintheuseofe-cigarettes high school students in southern California, Leventhal et al80
and vaping devices globally among youth and young adults. found that even when adjusted for various sociodemographic,
E-cigaretteshavebecomefirmlyestablishedasthemostcommonly
environmental, and intrapersonal factors including risk behav-
used tobacco product among youth in the United States since iors, baseline e-cigarette use was associated with a significant
2014.75,76 In 2020, nearly one in five high school students increaseintheoddsoftraditionalcigarettesmokinginthesimilar
(19.6%) reported currently using e-cigarettes.75,77 The ongoing range of 1.75 to 2.96 (OR), depending on the outcome.
adoption of e-cigarettes among America’s youth has garnered Furthermore,inameta-analysisofnineUS-basedstudies,Soneji
significantrecentattention frompublichealthadvocates,because et al82 reported a concordant pooled OR for subsequent tradi-
theiruptakehasdampenedeffortstocombattobaccoproductuse tional cigarette smoking of 3.62 (95% CI, 2.42-5.41) for ever
among adolescents. E-cigarette popularity is to blame for the versus never e-cigarette users, after adjusting for known de-
concerning plateau in the use of tobacco products among high mographic, psychosocial, and behavioral risk factors for tradi-
school students. More than one in four high school students tionalcigarettesmoking,withanevenhigherrelativeORof4.28
(26.3%)continue to report currentuse oftobacco products.75,77 (95%CI,2.52-7.27)amongyouthswhoreportede-cigaretteuse
in the past 30 days.
Potential for relative harm reduction in youth
tobacco product use Addictive potential and evolving e-cigarette
Some authors have proposed that this shift to using e-ciga- technology
rettes among youths is a positive trend, arguing that this may One recently published study comparatively evaluating data
represent a relative reduction in harm compared with the sig- from the more recent PATH study waves 4 to 4.5 (years 2016-
nificant short- and long-term risks of traditional tobacco smok- 2018) and 4.5 to 5 (years 2017-2019) shows that whereas this
ing.Forexample,intheircross-sectionalmatchedcontrolstudy, strong association between ever e-cigarette use and subsequent
Shahab et al78 used behavioral controls and propensity score transitiontocombustiblecigarettesmokingheldinwaves1to3,
matching within data between the 2014 and 2017 National an attenuation of the significance of this transition occurs in
Youth Tobacco Surveys to compare cigarette smoking rates of waves4to4.5(adjustedOR[aOR]¼1.40;95%CI,0.91-2.14)
adolescentswhofirsttriede-cigarettescomparedwiththosewho and in waves 4.5 to 5 (aOR ¼ 1.35; 95% CI, 0.84-2.16),85
first tried cigarettes or more traditional tobacco products. They despite the relatively high ongoing use of e-cigarettes as the
foundthatcomparedwithadolescentswhohadtriedatraditional current tobacco product of choice among youths in the United
cigaretteastheirfirsttobaccoinitiationproduct,adolescentswho States.77Onetheoryforthisisthatnewer-generatione-cigarettes
had used an e-cigarette first were less likely to be both past andENDSforvapingaremoreefficientatnicotinedeliveryand
30-daycigarettesmokers(OR¼0.15;95%CI,0.12-0.18)and maybesupplantingtheneedfortraditionalcombustiblecigarette
establishedcigarettesmokers(OR¼0.04;95%CI,0.03-0.07). use to obtain a greater high once dependence has occurred.86,87
This suggests that youths who try e-cigarettes as their first to- Historically traditional combustible cigarettes have allowed for
bacco product may be less likely to transition to traditional to- thefastestandmostefficientdeliveryofnicotineamongthearray
baccoproductsinthefuturerelativetothosewhosefirsttobacco of available tobacco products,79,86,88 reinforcing their status as2848 GIOVACCHINIETAL JALLERGYCLINIMMUNOLPRACT
NOVEMBER2022
some of the most addictive products sold on commercial mar- thepossiblecontributionofhigherpeaklevelnicotineexposures,
kets.However,themorerecentadventofcustomizablePodMod addiction rates, and withdrawal symptoms from the popular
devicescoupledwithinnovationsinnicotinechemistryallowfor newer-generation nicotinic salt formulation e-cigarette and
the use of less caustic protonated nicotine formulations derived ENDS as a likely contributor to their findings. Concordantly,
from the nicotine salts in loose-leaf tobacco as well as perhaps Zhang et al103 found that among youths currently using e-cig-
even more appealing, completely synthetic nicotine salts. Thus, arettes, 63.9% reported the desire to attempt to quit e-cigarette
newer-generatione-cigarettesandENDSarenowabletodeliver use, and that those reporting current nicotine dependency
muchhighernicotineconcentrationsthancombustiblecigarettes symptoms were more concerned about the e-cigarette use and
without the traditional acerbic taste and inhalational effects more likely to have made a past-year attempt to quit (adjusted
commonly associated with combustible cigarettes.86,87,89-92 prevalence ratio ¼ 1.17; 95% CI, 1.06-1.29). This underscores
These devices have additional appeal among youths because the need for a comprehensive approach to tobacco prevention
theyoftenhavesleek,easilyconcealeddesignsresemblingpensor and control among this new generation of youths for whom
USBdevicesorareevenmadetoresemblesmartphones,gaming nicotinedependenceisdevelopingthrougheventhesoleuseofe-
devices, and popular cartoon characters.86,87,93 Furthermore, cigarettes as the only tobacco product.
newer-generation salt-based nicotine e-liquids are available in a
hostofattractivefruity,minty,andcandy-basedflavorsthathold Regulation efforts and youths’ access to
e-cigarettes
appeal for youthful users, which can further mask subjective
caustic initial effects of higher-dose nicotine inhalation,86,87,94 Taken together, it is unsurprising that the evolving body of
are associated with an increased odds of adolescent vaping literature on the use of e-cigarettes among youths has caused a
continuation (aOR ¼ 3.76; 95% CI, 1.20-10.31) and a higher significantamountofconsternationamongthoseconcernedwith
level of nicotine-containing puffs taken on each vaping event thehealthandwell-beingofadolescentsandyoungadults.Calls
(mean, 3.1 (cid:2) 5.5 vs 1.5 (cid:2) 3.8), compared with the use of have arisen for stronger regulatory actions in the e-cigarette and
unflavored tobacco or menthol flavors among youths who use ENDS device markets.75,77,86,87,104-106 In recent years, these
e-cigarettes.94 Data from the most recent 2021 NYTS revealed calls have led to efforts at the federal level by the FDA to limit
that among youths currently using e-cigarettes, the most the sales of e-cigarettes to America’s youth by increasing the
commonly used device type was disposables. Both high school federal minimum legal sales age for all tobacco products
and middle school students reported that their usual brand of including e-cigarettes from 18 to 21 years across the United
choice was Puff Bar (Puff Bar, Wilmington, DE; 26.1% and States.104,107 The FDA also put forth a prioritized effort to
30.3%, respectively),75 a nicotinic saltebased product with fla- regulate flavored, prefilled cartridge-based e-cigarettes as of
vors such as Guava Ice and Strawberry Banana. In fact, likely 2020.75,108 Perhaps owing to these efforts, data from the Na-
owingtothiscombinationofreducedacridity,potentiallyhigher tional Youth Tobacco Surveys demonstrated that current use of
nicotinecontent,andwidelyavailablerangeofflavors,allofthe e-cigarettes declined for the first time in recent years between
most recently reported top brands of choice favored among 2019and2020amongbothhighschool(27.5%to19.6%)and
youths currently using e-cigarettes including Puff Bar, VUSE middle school students (10.5% to 4.7%).77
(R.J. Reynolds Vapor Company, Winston-Salem, NC), SMOK However, loopholes still exist in the ongoing development of
(Shenzhen IVPS Technology CO., Shenzhen, China), and flavored products and persistent pervasive marketing targeted at
JUUL (Altria Group, Richmond, VA),75 offer nicotine underaged e-cigarette users. Approximately 68% of US middle
saltebasedproductsastop-sellingproductswithincreasinggains and high school students reported ongoing exposure to e-ciga-
in sales market share.95 retteadvertisementsfrombothphysicalretailstoresandInternet-
The use of these newer, rapidly absorbed, salt-based nicotine based sources in 2020.109 Furthermore, a recent survey among
products and subsequent regular high-level exposure tonicotine youthsandyoungadultsinCaliforniarevealedthatdespitebeing
among youths creates additional concern for public health offi- underthelegalageof21requiredforvapingdevicepurchasesin
cials because it is well-known that the developing adolescent that state, most users (59.9%) reported being able to purchase
brain is particularly susceptible to the effects of nicotine, which theirowndevicesbothinpersonatvapeshopsandfromonline
has been shown to influence long-term molecular, biochemical, retailers.92Ongoingfederal,state,andlocaleffortstopreventand
and functional changes that increase the risk for future subse- reduce youth tobacco product use, including the use of e-ciga-
quent addictive behaviors, risk taking, and substance depen- rettes, will be imperative as the landscape of youth e-cigarette
dence.89,96,97 Moreover, numerous studies have demonstrated exposure continues to evolve.
the association between e-cigarette use among youths and other
risk-takingbehaviorsincludingtheuseofalcoholandprogression CONCLUSION
to other regular substance use including inhalational Although e-cigarettes are a relatively new addition to the to-
cannabis.89,96-99 Furthermore, youths’ exposure to nicotine via bacco product market, their recent uptake among consumers,
e-cigarettesisassociatedwithincreasedriskformood,attention, particularlyamongyouthsandyoungadults,warrantssignificant
and sleep disorders.86,91,97,100-102 Perhaps most concerningly, attention given the potential implications for both individual-
Kim et al101 found that after adjusting for a variety of socio- level and population-based health outcomes. Currently, the
economic demographics, risk-taking behaviors, and reported negativeeffectsofe-cigaretteuseseemtooutweighanypotential
stress levels, both male and female adolescents who used e-cig- benefit,because the available evidence doesnot confirm the use
arettes had significantly higher rates of suicidal ideation, suicide of e-cigarettes as an effective strategy for supporting traditional
planning, and actual suicide attempts than either traditional combustible tobacco cigarette smoking cessation, particularly
combustible cigarette users or never-smokers. The authors cited owing to the emerging adverse effects on lung health andJALLERGYCLINIMMUNOLPRACT GIOVACCHINIETAL 2849
VOLUME10,NUMBER11
potential future public health effects of e-cigarette adoption 25. JankowskiM,KrzystanekM,ZejdaJE,MajekP,LubanskiJ,LawsonJA,etal.
among a burgeoning new generation of tobacco product users. E-cigarettes are more addictive than traditional cigarettes-a study in highly
educatedyoungpeople.IntJEnvironResPublicHealth2019;16:2279.
26. EverardCD,SilveiraML,KimmelHL,MarshallD,BlancoC,ComptonWM.
REFERENCES
Associationofelectronicnicotinedeliverysystemusewithcigarettesmoking
1. Caponnetto P, Russo C, Bruno CM, Alamo A, Amaradio MD, Polosa R.
relapseamongformersmokersintheUnitedStates.JAMANetwOpen2020;
Electroniccigarette:apossiblesubstituteforcigarettedependence.Monaldi
3:e204813.
ArchChestDis2013;79:12-9.
27. McMillenR,KleinJD,WilsonK,WinickoffJP,TanskiS.E-cigaretteuseand
2. WeaverM,BrelandA,SpindleT,EissenbergT.Electroniccigarettes:areview
future cigarette initiation among never smokers and relapse among former
ofsafetyandclinicalissues.JAddictMed2014;8:234-40.
smokersinthePATHstudy.PublicHealthRep2019;134:528-36.
3. GilbertAH,inventor.SmokelessNon-TobaccoCigarette.AccessedAugust9,
28. BeardE,BrownJ,MichieS,WestR.Isprevalenceofe-cigaretteandnicotine
2022.https://patents.google.com/patent/US3200819A/en
replacement therapy use among smokers associated with average cigarette
4. Centers for Disease Control and Prevention. Introduction, conclusions, and
consumptioninEngland?Atime-seriesanalysis.BMJOpen2018;8:e016046.
historicalbackgroundrelativetoe-cigarettes. AccessedJune27,2022.https://
29. YuV,RahimyM,KorrapatiA,XuanY,ZouAE,KrishnanAR,etal.Elec-
www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/pdfs/2016_SGR_Chap_
troniccigarettesinduceDNAstrandbreaksandcelldeathindependentlyof
1_508.pdf
nicotineincelllines.OralOncol2016;52:58-65.
5. ChenJC,DasB,MeadEL,BorzekowskiDLG.Flavorede-cigaretteuseand
30. AndersonC,MajesteA,HanusJ,WangS.E-cigaretteaerosolexposurein-
cigarettesmokingsusceptibilityamongyouth.TobRegulSci2017;3:68-80.
duces reactive oxygen species, DNA damage, and cell death in vascular
6. ZhuSH,SunJY,BonnevieE,CumminsSE, GamstA,Yin L,etal.Four
endothelialcells.ToxicolSci2016;154:332-40.
hundredandsixtybrandsofe-cigarettesandcounting:implicationsforproduct
31. Lee HW, Park SH, Weng MW, Wang HT, Huang WC, Lepor H, et al.
regulation.TobControl2014;23(suppl3):iii3-9.
E-cigarettesmokedamagesDNAandreducesrepairactivityinmouselung,
7. BenowitzNL,Goniewicz ML.Theregulatory challenge ofelectronic ciga-
heart,andbladderaswellasinhumanlungandbladdercells.ProcNatlAcad
rettes.JAMA2013;310:685-6.
SciUSA2018;115:E1560-9.
8. CampusB,FafardP,StPierreJ,HoffmanSJ.Comparingtheregulationand
32. HamadSH,BrinkmanMC,TsaiYH,MelloukN,CrossK,JaspersI,etal.Pilot
incentivization of e-cigarettes across 97 countries. Soc Sci Med 2021;291:
studytodetectgenesinvolvedinDNAdamageandcancerinhumans:po-
114187.
tentialbiomarkersofexposuretoe-cigaretteaerosols.Genes(Basel)2021;12:
9. CollinsL,GlasserAM,AbudayyehH,PearsonJL,VillantiAC.E-cigarette
448.
marketingandcommunication:howe-cigarettecompaniesmarkete-cigarettes
33. WeenMP,MoshenskyA,ThredgoldLL,BastianNA,HamonR,BadieiA,
andthepublicengageswithe-cigaretteinformation.NicotineTobRes2019; etal.E-cigarettesandhealthrisks:moretotheflavourthanjustthename.AmJ
21:14-24.
PhysiolLungCellMolPhysiol2021;320:L600-14.
10. Patil S, Arakeri G, Patil S, Ali Baeshen H, Raj T, Sarode SC, et al. Are
34. Williams M, Villarreal A, BozhilovK, Lin S, Talbot P. Metal and silicate
electronicnicotinedeliverysystems(ENDs)helpingcigarettesmokersquit?-
particlesincludingnanoparticlesarepresentinelectroniccigarettecartomizer
Currentevidence.JOralPatholMed2020;49:181-9. fluidandaerosol.PLoSOne2013;8:e57987.
11. Flacco ME, Fiore M, Acuti Martellucci C, Ferrante M, Gualano MR,
35. HwangJH,LyesM,SladewskiK,EnanyS,McEachernE,MathewDP,etal.
LiguoriG,etal.Tobaccovs.electroniccigarettes:absenceofharmreduction
Electronic cigarette inhalation alters innate immunity and airway cytokines
aftersixyearsoffollow-up.EurRevMedPharmacolSci2020;24:3923-34.
whileincreasingthevirulenceofcolonizingbacteria.JMolMed(Berl)2016;
12. FarsalinosKE,KistlerKA,GillmanG,VoudrisV.Evaluationofelectronic
94:667-79.
cigarette liquids and aerosol for the presence of selected inhalation toxins.
36. SancilioS,GalloriniM,CataldiA,diGiacomoV.Cytotoxicityandapoptosis
NicotineTobRes2015;17:168-74. inductionbye-cigarettefluidsinhumangingivalfibroblasts.ClinOralInvestig
13. Farsalinos KE, Voudris V, Poulas K. Are metals emitted from electronic
2016;20:477-83.
cigarettesareasonforhealthconcern?Arisk-assessmentanalysisofcurrently
37. TangMS,WuXR,LeeHW,XiaY,DengFM,MoreiraAL,etal.Electronic-
availableliterature.IntJEnvironResPublicHealth2015;12:5215-32.
cigarettesmokeinduceslungadenocarcinomaandbladderurothelialhyper-
14. WangRJ,BhadrirajuS,GlantzSA.E-cigaretteuseandadultcigarettesmoking
plasiainmice.ProcNatlAcadSciUSA2019;116:21727-31.
cessation:ameta-analysis.AmJPublicHealth2021;111:230-46.
38. SzafranBN,PinkstonR,PerveenZ,RossMK,MorganT,PaulsenDB,etal.
15. Lorkiewicz P, Riggs DW, Keith RJ, Conklin DJ, Xie Z, Sutaria S, et al. Electronic-cigarettevehiclesandflavoringaffectlungfunctionandimmune
Comparison of urinary biomarkers of exposure in humans using electronic
responsesinamurinemodel.IntJMolSci2020;21:6022.
cigarettes,combustiblecigarettes,andsmokelesstobacco.NicotineTobRes
39. GlynosC,BibliSI,KatsaounouP,PavlidouA,MagkouC,KaravanaV,etal.
2019;21:1228-38.
Comparisonoftheeffectsofe-cigarettevaporwithcigarettesmokeonlung
16. GoniewiczML,KnysakJ,GawronM,KosmiderL,SobczakA,KurekJ,etal. functionandinflammationinmice.AmJPhysiolLungCellMolPhysiol2018;
Levelsofselectedcarcinogensandtoxicantsinvapourfromelectronicciga-
315:L662-72.
rettes.TobControl2014;23:133-9.
40. Tackett AP, Keller-Hamilton B, Smith CE, Hebert ET, Metcalf JP,
17. GoniewiczML,KumaT,GawronM,KnysakJ,KosmiderL.Nicotinelevelsin
QueimadoL,etal.Evaluationofrespiratorysymptomsamongyouthe-ciga-
electroniccigarettes.NicotineTobRes2013;15:158-66.
retteusers.JAMANetwOpen2020;3:e2020671.
18. DaiH,BenowitzNL,AchutanC,FaraziPA,DegaregeA,KhanAS.Exposure
41. Lee WK, Smith CL, Gao CX, Borg BM, Nilsen K, Brown D, et al. Are
totoxicantsassociatedwithuseandtransitionsbetweencigarettes,e-cigarettes,
e-cigaretteuseandvapingassociatedwithincreasedrespiratorysymptomsand
andnotobacco.JAMANetwOpen2022;5:e2147891. poorerlungfunctioninapopulationexposedtosmokefromacoalminefire?
19. BakerTB,PiperME,SteinJH,SmithSS,BoltDM,FraserDL,etal.Effectsof
Respirology2021;26:974-81.
nicotinepatchvsvareniclinevscombinationnicotinereplacementtherapyon 42. LiD,SundarIK,McIntoshS,OssipDJ,GoniewiczML,O’ConnorRJ,etal.
smokingcessationat26weeks:arandomizedclinicaltrial.JAMA2016;315:
Associationofsmokingandelectroniccigaretteusewithwheezingandrelated
371-9.
respiratory symptoms in adults: cross-sectional results from the Population
20. RosenLJ,GaliliT,KottJ,GoodmanM,FreedmanLS.Diminishingbenefitof
AssessmentofTobaccoandHealth(PATH)study,wave2.TobControl2020;
smokingcessationmedicationsduringthefirstyear:ameta-analysisofran-
29:140-7.
domizedcontrolledtrials.Addiction2018;113:805-16.
43. LiD, XieZ.Cross-sectionalassociation oflifetime electroniccigaretteuse
21. RigottiNA,KruseGR,Livingstone-BanksJ,Hartmann-BoyceJ.Treatmentof
withwheezingandrelatedrespiratorysymptomsinU.S.adults.NicotineTob
tobaccosmoking:areview.JAMA2022;327:566-77.
Res2020;22(suppl1):S85-92.
22. WalkerN,ParagV,VerbiestM,LakingG,LaugesenM,BullenC.Nicotine
44. McFadden DD, Bornstein SL, Vassallo R, Salonen BR, Bhuiyan MN,
patchesusedincombinationwithe-cigarettes(withandwithoutnicotine)for
Schroeder DR, et al. Symptoms COVID 19 positive vapers compared to
smokingcessation:apragmatic,randomisedtrial.LancetRespirMed2020;8:
COVID 19 positive non-vapers. J Prim Care Community Health 2022;13:
54-64.
21501319211062672.
23. HajekP,Phillips-WallerA,PrzuljD,PesolaF,MyersSmithK,BisalN,etal.
45. GaihaSM,ChengJ,Halpern-FelsherB.Associationbetweenyouthsmoking,
Arandomizedtrialofe-cigarettesversusnicotine-replacementtherapy.NEngl
electroniccigaretteuse,andCOVID-19.JAdolescHealth2020;67:519-23.
JMed2019;380:629-37.
46. AxelssonGT,EythorssonES,HardardottirH,GudmundssonG,HansdottirS.
24. MushtaqN,BeebeLA.PsychometricpropertiesofFagerstromtestfornicotine
Theimpactoflungdiseases,smokingande-cigaretteuseontheseverityof
dependenceforsmokelesstobaccousers(FTND-ST).NicotineTobRes2017;
COVID-19illnessatdiagnosis[inIcelandic].Laeknabladid2020;106:574-9.
19:1095-101.2850 GIOVACCHINIETAL JALLERGYCLINIMMUNOLPRACT
NOVEMBER2022
47. GaoM,AveyardP,LindsonN,Hartmann-BoyceJ,WatkinsonP,YoungD, 71. Crotty Alexander LE, Ware LB, Calfee CS, Callahan SJ, Eissenberg T,
etal.Associationbetweensmoking,e-cigaretteuseandsevereCOVID-19:a Farver C, et al. NIH Workshop Report: e-cigarette or vaping product use
cohortstudy.IntJEpidemiol.PublishedonlineFebruary18,2022.https://doi. associatedlunginjury(EVALI):developingaresearchagenda.AmJRespir
org/10.1093/ije/dyac028. CritCareMed2020;202:795-802.
48. Masso-Silva JA, Moshensky A, Shin J, Olay J, Nilaad S, Advani I, et al. 72. Odish MF, Bellinghausen A, Golts E, Owens RL. E-cigarette, or vaping,
Chronice-cigaretteaerosolinhalationalterstheimmunestateofthelungsand productuse-associatedlunginjury(EVALI)treatedwithveno-venousextra-
increasesACE2expression,raisingconcernforalteredresponseandsuscep- corporealmembraneoxygenation(VV-ECMO)andultra-protectiveventilator
tibilitytoSARS-CoV-2.FrontPhysiol2021;12:649604. settings.BMJCaseRep2020;13:e234771.
49. McAlinden KD, Lu W, Ferdowsi PV, Myers S, Markos J, Larby J, et al. 73. AlnajemA,RedhaA,AlroumiD,AlshammasiA,AliM,AlhussainiM,etal.
Electronic cigarette aerosol is cytotoxic and increases ACE2 expression on Use of electronic cigarettes and secondhand exposure to their aerosols are
human airway epithelial cells: implications for SARS-CoV-2 (COVID-19). associatedwithasthmasymptomsamongadolescents:across-sectionalstudy.
JClinMed2021;10:1028. RespirRes2020;21:300.
50. LallaiV,MancaL,FowlerCD.E-cigarettevapeandlungACE2expression: 74. GaliatsatosP,GomezE,LinCT,IlleiPB,ShahP,NeptuneE.Secondhand
implicationsforcoronavirusvulnerability.EnvironToxicolPharmacol2021; smokefromelectroniccigaretteresultinginhypersensitivitypneumonitis.BMJ
86:103656. CaseRep2020;13:e233381.
51. Madison MC, Landers CT, Gu BH, Chang CY, Tung HY, You R, et al. 75. Park-LeeE,RenC,SawdeyMD,GentzkeAS,CorneliusM,JamalA,etal.
Electroniccigarettesdisruptlunglipidhomeostasisandinnateimmunityin- Notesfromthefield:e-cigaretteuseamongmiddleandhighschoolstudents-
dependentofnicotine.JClinInvest2019;129:4290-304. NationalYouthTobaccoSurvey,UnitedStates,2021.MMWRMorbMortal
52. SivaramanV,ParkerD,ZhangR,JonesMM,OnyenwokeRU.Vapingex- WklyRep2021;70:1387-9.
acerbatescoronavirus-relatedpulmonaryinfectioninamurinemodel.Front 76. ArrazolaRA,SinghT,CoreyCG,HustenCG,NeffLJ,ApelbergBJ,etal.
Physiol2021;12:634839. Tobaccouseamongmiddleandhighschoolstudents-UnitedStates,2011-
53. SerpaGL,RentonND,LeeN,CraneMJ,JamiesonAM.Electronicnicotine 2014.MMWRMorbMortalWklyRep2015;64:381-5.
deliverysystemaerosol-induced celldeathanddysfunctioninmacrophages 77. GentzkeAS,WangTW,JamalA,Park-LeeE,RenC,CullenKA,etal.To-
andlungepithelialcells.AmJRespirCellMolBiol2020;63:306-16. baccoproductuseamongmiddleandhighschoolstudents-UnitedStates,
54. WeenMP,WhittallJJ,HamonR,ReynoldsPN,HodgeSJ.Phagocytosisand 2020.MMWRMorbMortalWklyRep2020;69:1881-8.
inflammation:exploringtheeffectsofthecomponentsofE-cigarettevaporon 78. ShahabL,BeardE,BrownJ.Associationofinitiale-cigaretteandotherto-
macrophages.PhysiolRep2017;5:e13370. baccoproductusewithsubsequentcigarettesmokinginadolescents:across-
55. CorridenR,MoshenskyA,BojanowskiCM,MeierA,ChienJ,NelsonRK, sectional,matchedcontrolstudy.TobControl2021;30:212-20.
etal.E-cigaretteuseincreasessusceptibilitytobacterialinfectionbyimpair- 79. XuS,CoffmanDL,LiuB,XuY,HeJ,NiauraRS.Relationshipsbetween
mentofhumanneutrophilchemotaxis,phagocytosis,andNETformation.Am E-cigaretteuseandsubsequentcigaretteinitiationamongadolescentsinthe
JPhysiolCellPhysiol2020;318:C205-14. PATHstudy:anentropybalancingpropensityscoreanalysis.PrevSci2022;
56. Crotty Alexander LE, Drummond CA, Hepokoski M, Mathew D, 23:608-17.
Moshensky A, Willeford A, et al. Chronic inhalation of e-cigarette vapor 80. LeventhalAM,StrongDR,KirkpatrickMG,UngerJB,SussmanS,RiggsNR,
containing nicotine disrupts airway barrier function and induces systemic et al. Association of electronic cigarette use with initiation of combustible
inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr tobaccoproductsmokinginearlyadolescence.JAMA2015;314:700-7.
CompPhysiol2018;314:R834-47. 81. PrimackBA,SonejiS,StoolmillerM,FineMJ,SargentJD.Progressionto
57. HaganC.Whenaremiceconsideredold?AccessedJune27,2022.https://www. traditionalcigarettesmokingafterelectroniccigaretteuseamongUSadoles-
jax.org/news-and-insights/jax-blog/2017/november/when-are-mice-considered-old centsandyoungadults.JAMAPediatr2015;169:1018-23.
58. Garcia-ArcosI,GeraghtyP,BaumlinN,CamposM,DaboAJ,JundiB,etal. 82. Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB,
ChronicelectroniccigaretteexposureinmiceinducesfeaturesofCOPDina GibsonLA,etal.Associationbetweeninitialuseofe-cigarettesandsubse-
nicotine-dependentmanner.Thorax2016;71:1119-29. quent cigarette smokingamongadolescentsand youngadults:asystematic
59. ReinikovaiteV,RodriguezIE,KaroorV,RauA,TrinhBB,DeleyiannisFW, reviewandmeta-analysis.JAMAPediatr2017;171:788-97.
etal.Theeffectsofelectroniccigarettevapouronthelung:directcomparison 83. Barrington-TrimisJL,KongG,LeventhalAM,LiuF,MayerM,CruzTB,
totobaccosmoke.EurRespirJ2018;51:1701661. etal.E-cigaretteuseandsubsequentsmokingfrequencyamongadolescents.
60. Han H, Peng G, Meister M, Yao H, Yang JJ, Zou MH, et al. Electronic Pediatrics2018;142:e20180486.
cigarette exposure enhances lung inflammatory and fibrotic responses in 84. Barrington-Trimis JL, Urman R, Berhane K, Unger JB, Cruz TB,
COPDmice.FrontPharmacol2021;12:726586. PentzMA,etal.E-cigarettesandfuturecigaretteuse.Pediatrics2016;138:
61. Alanazi H, Semlali A, Chmielewski W, Rouabhia M. E-cigarettes increase e20160379.
Candidaalbicansgrowthandmodulateitsinteractionwithgingivalepithelial 85. SunR,MendezD,WarnerKE.Isadolescente-cigaretteuseassociatedwith
cells.IntJEnvironResPublicHealth2019;16:294. subsequentsmoking?Anewlook.NicotineTobRes2022;24:710-8.
62. MoshenskyA,BrandCS,AlhaddadH,ShinJ,Masso-SilvaJA,AdvaniI,etal. 86. Barrington-TrimisJL,LeventhalAM.Adolescents’useof"PodMod"e-cig-
Effectsofmangoandmintpod-basede-cigaretteaerosolinhalationoninflam- arettes-urgentconcerns.NEnglJMed2018;379:1099-102.
matorystatesofthebrain,lung,heart,andcoloninmice.Elife2022;11:e67621. 87. KongG,ChaffeeBW,WuR,Krishnan-SarinS,LiuF,LeventhalAM,etal.
63. Chaaban T. Acute eosinophilic pneumonia associated with non-cigarette E-cigarettedevicetypeandcombustibletobaccouse:resultsfromapooled
smokingproducts:asystematicreview.AdvRespirMed2020;88:142-6. analysisof10,482youth.DrugAlcoholDepend2022;232:109279.
64. Sommerfeld CG, Weiner DJ, Nowalk A, Larkin A. Hypersensitivity pneu- 88. HoggRC.Contributionofmonoamineoxidaseinhibitiontotobaccodepen-
monitisandacuterespiratorydistresssyndromefrome-cigaretteuse.Pediatrics dence:areviewoftheevidence.NicotineTobRes2016;18:509-23.
2018;141:e20163927. 89. Goldenson NI, Leventhal AM, Stone MD, McConnell RS, Barrington-
65. NairN,HurleyM,GatesS,DaviesP,ChenIL,ToddI,etal.Life-threatening Trimis JL. Associations of electronic cigarette nicotine concentration with
hypersensitivitypneumonitissecondarytoe-cigarettes.ArchDisChild2020; subsequentcigarettesmokingandvapinglevelsinadolescents.JAMAPediatr
105:1114-6. 2017;171:1192-9.
66. LandmanST,DhaliwalI,MackenzieCA,MartinuT,SteeleA,BosmaKJ. 90. GoniewiczML,BoykanR,MessinaCR,EliscuA,TolentinoJ.Highexposure
Life-threateningbronchiolitisrelatedtoelectroniccigaretteuseinaCanadian to nicotine among adolescents who use Juul and other vape pod systems
youth.CMAJ2019;191:E1321-31. (’pods’).TobControl2019;28:676-7.
67. Khan MS, Khateeb F, Akhtar J, Khan Z, Lal A, Kholodovych V, et al. 91. FadusMC,SmithTT,SquegliaLM.Theriseofe-cigarettes,podmoddevices,
Organizingpneumoniarelatedtoelectroniccigaretteuse:acasereportand and JUUL among youth: factors influencing use, health implications, and
reviewofliterature.ClinRespirJ2018;12:1295-9. downstreameffects.DrugAlcoholDepend2019;201:85-93.
68. EdmondsPJ,CopelandC,CongerA,RichmondBW.Vaping-induceddiffuse 92. Cwalina SN, BraymillerJL,Leventhal AM, Unger JB, McConnell R,Bar-
alveolarhemorrhage.RespirMedCaseRep2020;29:100996. rington-TrimisJL.Prevalenceofyoungadultvaping,substancevaped,and
69. AgustinM,YamamotoM,CabreraF,EusebioR.Diffusealveolarhemorrhage purchaselocationacrossfivecategoriesofvapingdevices.NicotineTobRes
inducedbyvaping.CaseRepPulmonol2018;2018:9724530. 2021;23:829-35.
70. HayesDJr,BoardA,CalfeeC,EllingtonS,PollackLA,KathuriaH,etal. 93. KongG,BoldKW,MoreanME,BhattiH,CamengaDR,JacksonA,etal.
Pulmonaryandcriticalcareconsiderationsfore-cigarette,orvaping,product Appeal of JUUL among adolescents. Drug Alcohol Depend 2019;205:
use-associatedlunginjury(EVALI).Chest2022;162:256-64. 107691.JALLERGYCLINIMMUNOLPRACT GIOVACCHINIETAL 2851
VOLUME10,NUMBER11
94. Leventhal AM, Goldenson NI, Cho J, Kirkpatrick MG, McConnell RS, 103. ZhangL,GentzkeA,TriversKF,VanFrankB.Tobaccocessationbehaviors
StoneMD,etal.Flavorede-cigaretteuseandprogressionofvapinginado- amongU.S.middleandhighschoolstudents,2020.JAdolescHealth2022;70:
lescents.Pediatrics2019;144:e20190789. 147-54.
95. AliFRM,DiazMC,ValloneD,TynanMA,CordovaJ,SeamanEL,etal. 104. RappJL,AlpertN,WilsonKM,FloresRM,TaioliE.Changesine-cigarette
E-cigaretteunitsales,byproductandflavortype-UnitedStates,2014-2020. perceptionsovertime:aNationalYouthTobaccoSurveyanalysis.AmJPrev
MMWRMorbMortalWklyRep2020;69:1313-8. Med2021;61:174-81.
96. RenM,LotfipourS.Nicotinegatewayeffectsonadolescentsubstanceuse. 105. Barrington-TrimisJL,BerhaneK,UngerJB,CruzTB,UrmanR,ChouCP,
WestJEmergMed2019;20:696-709. etal.Thee-cigarettesocialenvironment,e-cigaretteuse,andsusceptibilityto
97. Chadi N, Hadland SE, Harris SK. Understanding the implications of the cigarettesmoking.JAdolescHealth2016;59:75-80.
"vaping epidemic" among adolescents and young adults: a call for action. 106. WangTW,NeffLJ,Park-LeeE,RenC,CullenKA,KingBA.E-cigaretteuse
SubstAbus2019;40:7-10. amongmiddleandhighschoolstudents-UnitedStates,2020.MMWRMorb
98. StaffJ,VuoloM,KellyBC,MaggsJL,SilvaCP.Electroniccigaretteusein MortalWklyRep2020;69:1310-2.
adolescenceisassociatedwithlatercannabisuse.DrugAlcoholDepend2022; 107. CentersforDiseaseControlandPrevention.STATESystemE-CigaretteFact
232:109302. Sheet. AccessedJune27,2022.https://www.cdc.gov/statesystem/factsheets/
99. GiovacchiniCX,PacekL,McClernonFJ,QueLG.Useandperceivedriskof ecigarette/ECigarette.html#:w:text¼A%20federal%20law%20enacted%20on,21%
electroniccigarettesamongNorthCarolinamiddleandhighschoolstudents. 20across%20the%20United%20States
NCMedJ2017;78:7-13. 108. US Food and Drug Administration. FDA finalizes enforcement policy on
100. LivingstonJA,ChenCH,KwonM,ParkE.Physicalandmentalhealthout- unauthorized flavored cartridge-based e-cigarettes that appeal to children,
comesassociatedwithadolescentE-cigaretteuse.JPediatrNurs2022;64:1-17. includingfruitandmint. AccessedJune27,2022.https://www.fda.gov/news-
101. KimSH,JeongSH,ParkEC,JangSI.Associationofcigarettetypeinitially events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridge-
smoked with suicidal behaviors among adolescents in Korea from 2015 to based-e-cigarettes-appeal-children
2018.JAMANetwOpen2021;4:e218803. 109. LiX,KaiserN,BorodovskyJT,RiordanR,KassonE,CaoC,etal.National
102. RiehmKE,Rojo-WissarDM,FederKA,MojtabaiR,SpiraAP,ThrulJ,etal. trendsofadolescentexposuretotobaccoadvertisements:2012-2020.Pediat-
E-cigaretteuseandsleep-relatedcomplaintsamongyouth.JAdolesc2019;76:48-54. rics2021;148:e2021050495.